Mode
Text Size
Log in / Sign up

Genetic Association of CDKAL1 rs7754840 Polymorphism with Gestational Diabetes Mellitus RiskGenetic Variant Linked to Higher Risk of Gestational Diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
The CDKAL1 rs7754840 polymorphism is significantly associated with increased GDM risk in Asian populations.

This meta-analysis evaluated the association between the CDKAL1 rs7754840 polymorphism and the risk of developing gestational diabetes mellitus (GDM). Analyzing data from 18 studies involving 8,025 women with GDM and 8,605 controls, the researchers aimed to identify genetic markers contributing to glucose intolerance during pregnancy.

Pooled analysis revealed a consistent association between the specific polymorphism and an increased risk of GDM. This correlation was particularly robust in Asian populations, where 15 studies provided consistent evidence. These findings suggest that the CDKAL1 variant may play a significant role in the pathophysiology of gestational diabetes in these groups.

In contrast, the evidence regarding the polymorphism in Caucasian populations remained inconclusive across the three included studies. Furthermore, Trial Sequential Analysis indicated that while the evidence was supportive, it had not reached the required information size to be definitive. Clinicians should note that while the association is strong in specific ethnicities, the genetic risk profile varies significantly across different populations.

Researchers analyzed data from 18 different studies involving over 16,000 women to look at the link between a specific genetic variant and gestational diabetes. This condition occurs when blood sugar levels become too high during pregnancy. The study focused on a genetic marker called CDKAL1 rs7754840.

The results showed a clear link between this genetic marker and an increased risk of gestational diabetes in Asian populations. However, the evidence for Caucasian populations was not clear. Because the study was a meta-analysis of existing data, it shows a link between genes and health risks rather than a direct cause.

It is important to note that the evidence is not yet definitive for everyone. Some statistical tests suggested that more data is needed to be certain of the findings. This research helps scientists understand how genetics might play a role in pregnancy health, but it does not change immediate medical practices.

What this means for you:
A specific genetic marker is linked to higher gestational diabetes risk in Asian populations, but results are unclear for others.

Common questions

What is the CDKAL1 rs7754840 polymorphism?

This is a specific genetic marker that researchers studied to see if it relates to health risks. The study found that this variant is linked to an increased risk of gestational diabetes, particularly in Asian populations. It is a way for scientists to study how genetics might influence how the body handles blood sugar during pregnancy.

Is this genetic link found in all ethnicities?

The evidence is not the same for everyone. While the study found a consistent link between the CDKAL1 rs7754840 variant and gestational diabetes in Asian populations, the results for Caucasian populations were inconclusive. This means the link is not yet proven for all groups of people.

Does this mean the gene causes gestational diabetes?

No, the study shows an association, not a direct cause. While the link was found in many cases, the evidence is still considered supportive but not definitive because the amount of information available is currently limited. You should speak with a doctor about your specific health risks.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Background and purposeGestational diabetes mellitus (GDM) is a widespread condition during pregnancy with substantial fetal and maternal morbidity. However, the correlation between GDM risk and the CDKAL1 rs7754840 polymorphism is inconsistent.This study aimed to comprehensively evaluate this association through an updated systematic review and meta-analysis.MethodsThis systematic review and meta-analysis was conducted in accordance with the PRISMA guidelines. A comprehensive literature search of case-control studies was conducted in CNKI, Embase, PubMed, Scopus, and Web of Science from database inception to December 17, 2025. Five genetic models were selected, along with their odds ratios (ORs) and 95% confidence intervals. Subsequently, stratified analyses were performed by ethnicity and according to diagnostic criteria for GDM. Heterogeneity, publication bias, and trial sequential analysis (TSA) were assessed.ResultsThe meta-analysis included 18 studies comprising 8,025 women with GDM and 8,605 controls. Pooled analyses showed an association between the CDKAL1 rs7754840 polymorphism and increased GDM risk, with moderate to substantial between-study heterogeneity across genetic models. Stratified analyses showed consistent associations in Asian populations (15 studies; 7,012 cases/7,921 controls), whereas evidence in Caucasian populations (3 studies; 1,013 cases/684 controls) was inconclusive. Heterogeneity varied across GDM diagnostic criteria, with lower heterogeneity observed among studies using the IADPSG (2010) criteria. TSA showed that the cumulative Z-curve crossed the monitoring boundary but did not reach the required information size, indicating supportive but inconclusive evidence.ConclusionsThis meta-analysis supports the association between GDM risk and CDKAL1 rs7754840 in Asian populations.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251270398, identifier CRD420251270398.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.